Clinical Trials /

MR-Guided Cryoablation of Prostate Bed Recurrences

NCT01727284

Description:

The purpose of this research is to see if MR-guided cryoablation can effectively treat prostate tumor recurrences.

Related Conditions:
  • Prostate Neoplasm
Recruiting Status:

Recruiting

Phase:

N/A

Trial Eligibility

Document

Title

  • Brief Title: MR-Guided Cryoablation of Prostate Bed Recurrences
  • Official Title: Technical Success, Safety, and Short and Long-term Efficacy for MR-Guided Cryoablation of Prostate Bed Recurrences

Clinical Trial IDs

  • ORG STUDY ID: 12-002245
  • NCT ID: NCT01727284

Conditions

  • Prostate Tumors

Purpose

The purpose of this research is to see if MR-guided cryoablation can effectively treat prostate tumor recurrences.

Trial Arms

NameTypeDescriptionInterventions
MR-guided cryoablation (freezing of tissue and/or tumors)Other

    Eligibility Criteria

            Inclusion Criteria:
    
              -  Patients with "biopsy proven" soft tissue tumor recurrences of prostate fossa
    
              -  Surgery is not a desirable alternative therapy at the time of enrollment
    
              -  Radiation therapy has failed or not indicated or can be safely postponed
    
              -  Tumor size is < 5 cm at its largest diameter
    
              -  Tumor does not encompass the rectal wall or external urethral sphincter
    
              -  Performance status is ECOG 2 or better in adults
    
              -  Patient is able to undergo MRI
    
            Exclusion Criteria:
    
              -  Patients with pacemaker or defibrillator
          
    Maximum Eligible Age:100 Years
    Minimum Eligible Age:30 Years
    Eligible Gender:Male
    Healthy Volunteers:No

    Primary Outcome Measures

    Measure:Evaluation of target lesion at 3-6, 12, 24, and 36 month imaging follow-up
    Time Frame:3 years
    Safety Issue:
    Description:

    Details

    Phase:N/A
    Primary Purpose:Interventional
    Overall Status:Recruiting
    Lead Sponsor:Mayo Clinic

    Last Updated

    April 4, 2017